​On. Target Molecules Biotech Inc seeks investors to accelerate our technology to market in keeping with the company's mission of providing a novel affordable cancer treatment to advance improvements in global health. 

Led by innovative thinking, ingenuity, and a steadfast determination in bringing about improvements in healthcare, O.TM Biotech has made rapid strides over the past years and is positioning itself for growth, diversification, licensing and potential joint ventures in multiple ways in the next 4-5 years. Currently three variable sequences leading to eight therapeutically significant and viable drug products are in the pipeline at O.TM Biotech and we intend to continue developing our novel biotech platform.

​Building on its success to date, O.TM Biotech is poised to take on the remaining phases in its fight against Cancer at scale and speed. The company is pioneering new technology dedicated to excellence in all metrics. ​

​
​The essential scope of the company is centered around
​proprietary innovation within the domain of disease therapeutics​

Therapeutic Solution for Cancer

About Our Work

The Company has established a path for success with its first variation of the patented antibodies and will produce several molecules in the near future for various indications of cancer. 

Why it Matters

O.TM Biotech is developing a minimally invasive, high safety, minimal side-effects treatment of cancer for patients.

Invest in O.TM Biotech

Unique proprietary technology with a new approach to Cancer Therapeutics

​
​Our innovative technology will have a tremendous impact in shaping global health care over the years to come.​

​Our hope is that you will join us in this endeavor.
For additional information please contact: ​[email protected]

On. Target Molecules Biotech Inc
​ Three unique approaches; each with the objective
​ of developing ​innovative technologies
​for Cancer Treatment 
​
​

On. Target Molecules Biotech ​ 

The Bio-Molecules are the production of Monoclonal Antibodies and scfv-hc expressed proteins from mammalian cell line culture of variable regions of Monoclonal Antibodies secreted by Murine Hybridoma cell lines against human cancers. ​The produced Monoclonal Antibodies and scfv-hc Proteins of the present invention bind to post Translational Modified Receptors in Cancer Cells and can be used for diagnosis and treatment of various cancers.

On. Polymer Molecules 

Nanoparticle Composites are designed and synthesized to bind and destroy a moving cell target. The architecture of the Nanoparticle is the key that locks onto a Bio-Marker expressed by a cancer cell. Cancers will be stopped in their tracks.​​The essential scope of On. Polymers Molecules is within the domain of diagnostics and therapeutics through affordable proprietary innovation that does away with Biologics.

On. Radio Frequency

Radio Frequency technology where a Biomedical RF device impinges radio frequencies on a metal ion encapsulated Nanoparticle for targeted RF Ablation of Cancer and Metastatic Cells. ​A unique RF machine that impinges frequencies on a target Nanoparticle that ablates a cancer cell where it is embedded. Radio frequencies range between 1000 Hz and 3 THz and should not be confused with radiation gamma knife treatment that utilizes the cobalt or other radioisotopes called radio therapy. The bringing together of two technologies namely Nanoparticles and radio frequencies has heralded a new approach to treating and perhaps curing cancer.